Profile

Business Description

Neuralstem is a biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need.  Our lead asset, NSI-189, is a new chemical entity in Phase 2 clinical development for major depressive disorder (MDD). Our transplantational stem cell asset, NSI-566, is a spinal cord-derived neural stem cell line being tested in stroke, chronic spinal cord injury (cSCI) and Amyotrophic Lateral Sclerosis (ALS).  These product candidates are based on the company’s proprietary neural stem cell technology.

Company Info

Address:
20271 Goldenrod Lane
Suite 2024
Germantown, MD 20876

Telephone:
301-366-4960

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC:
Biological Products, Except Diagnostic Substances (2836)